
Legal19 Mar 2026, 06:42 pm
Supha Pharmachem Ltd: NCLT Admits Insolvency Proceedings, Appoints IRP
AI Summary
The National Company Law Tribunal (NCLT), Mumbai Bench-VI has admitted an application under Section 9 of the Insolvency and Bankruptcy Code, 2016 against Supha Pharmachem Ltd (formerly Remedium Lifecare Limited). The NCLT has initiated the Corporate Insolvency Resolution Process (CIRP) and appointed Mr. Rajesh Jhunjhunwala as the Interim Resolution Professional (IRP). The order prohibits various actions including institution or continuation of suits or proceedings against the company, transfer or disposal of assets, enforcement of security interest, and recovery of property.
Key Highlights
- Admission of CIRP against Supha Pharmachem Ltd
- Appointment of Mr. Rajesh Jhunjhunwala as IRP
- Declaration of moratorium under Section 14 of the IBC
- Suspension of Board powers
- Public announcement of CIRP initiation by IRP